Rivkin Ovarian Cancer Research Symposium
Ovarian Cancer Research Alliance is proud to present the 16th Biennial Rivkin Ovarian Cancer Research Symposium on October 16-18, 2026 at the Sheraton Philadelphia Downtown in Philadelphia, PA.
In This Section
Symposium Information
Since 1996, leaders in ovarian cancer research and treatment have come together at this symposium to share the latest breakthroughs. The event fosters networking and collaboration through poster sessions, breakout discussions, and career development opportunities. Sessions will cover novel therapeutics, immuno-oncology, tumor microenvironment, early detection, prevention, cancer biology, rare tumors, epidemiology, health disparities, and patient advocacy.
-
To be announced in April. Session topics will be developed by the symposium co-chairs and will include invited talks and selected abstract presentations (oral and poster).
-
- April 14, 2026: Abstract Submission Opens
- May 26, 2026: Online Registration Opens
- July 14, 2026: Abstract Submission Closes
- August 18, 2026: Abstract Notifications
- Sept 1, 2026: Early Registration Closes – rate increase
-
Questions? Contact Jackie Lang, PhD, OCRA’s Director of Scientific Programs, at jlang@ocrahope.org or 212-268-1002.
Sign Up for Email Updates: Rivkin Ovarian Cancer Research Symposium
Registration
Early registration: May 26 – September 1, 2026.
Registration is online and requires full payment. Visa, MasterCard, and American Express are accepted. Confirmation is emailed automatically.
Note: This is an in-person meeting only. Breakfast and dinner are included.
Set a calendar reminder for registration opening:
Please note, this is not a Continuing Medical Education (CME) event.
Lodging & Travel
A discounted group rate is available at the symposium hotel:
Sheraton Philadelphia Downtown
201 North 17th Street
Philadelphia, Pennsylvania, USA, 19103
Tel: +1 215-448-2000
The group rate will be made available when registration opens on May 26, 2026.
-
The Sheraton is 8 miles from Philadelphia International Airport (PHL). No shuttle is available; we recommend taxi or ride share.
-
Secure underground parking at the Sheraton is $49 per day.
Program
The symposium programming will run from approximately 2 pm on Friday, October 16 – noon on Sunday, October 18, 2026. Exact times are subject to change as we develop the program. Keynotes, invited speakers, and session topics will be announced in April.
Abstracts
We welcome research and clinical abstracts across all areas of ovarian cancer research. Selected abstracts will be invited for 10-minute oral presentations; others may be accepted for posters. All presenters must register for the Symposium.
The abstract submission window is April 14 – July 14, 2026.
-
Abstract submission opening is April 14, 2026.
Abstract deadline will be Tuesday, July 14, 2026 at 8:00 pm ET / 5:00 pm PT.
-
- To be announced in April.
-
Decisions will be sent by email approximately August 18, 2026.
-
Abstracts will be posted online after the presenter accepts. Presenters will receive scheduling and format instructions by email.
-
All presenters must register. If an abstract is not selected, the presenting author may request a refund.
-
To withdraw an abstract at any time, log in, navigate to ‘Submission Home’, and select ‘Withdraw Submission’ under the abstract.
Co-Chairs
The chairs develop the symposium scope and program, including session topics and invited speakers, with an emphasis on advancing ovarian cancer research and supporting early-career investigators.
-
Duke University
-
University of Miami
-
University of British Columbia
-
Indiana University
-
University of Pennsylvania
Planning Committee
-
Director of Scientific Programs, Ovarian Cancer Research Alliance
Sponsors
OCRA gratefully acknowledges our exhibitors and sponsors. Their support makes this symposium possible.
To sponsor the 2026 Rivkin Ovarian Cancer Research Symposium, please email jlang@ocrahope.org.